EDITORIALS |
MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, London
Glyncynffig Hostel, Bridgend
MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, London, UK
Correspondence: Philip Asherson, MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Denmark Hill, London SE5 8AF, UK. Email: p.Asherson{at}iop.kcl.ac.uk
Declaration of interest The authors research is funded by the UKMedical Research Council, the Wellcome Trust and the US National Institute of Mental Health. P.A. received unrestricted research funds from Janssen-Cilag and has spoken at meetings sponsored by Janssen-Cilag and Eli Lilly.
Attention-deficit hyperactivity disorder (ADHD) is a common disorder affecting children and adults. Many young people treated with stimulants, as well as those in whom ADHD went unrecognised in childhood, need treatment as adults. Stimulants and atomoxetine effectively reduce ADHD symptoms at all ages and should be a standard treatment in general adult psychiatric practice.
Related articles in BJP:
This article has been cited by other articles:
![]() |
J Godfrey Safety of therapeutic methylphenidate in adults: a systematic review of the evidence J Psychopharmacol, March 1, 2009; 23(2): 194 - 205. [Abstract] [PDF] |
||||
![]() |
S. McCarthy, P. Asherson, D. Coghill, C. Hollis, M. Murray, L. Potts, K. Sayal, R. de Soysa, E. Taylor, T. Williams, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults The British Journal of Psychiatry, March 1, 2009; 194(3): 273 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Berney Developmental disorders come of age Psychiatr. Bull., January 1, 2009; 33(1): 1 - 3. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Kuan and A. H. Young Attention-deficit hyperactivity disorder and mood disorders in adults The British Journal of Psychiatry, August 1, 2007; 191(2): 181 - 182. [Full Text] [PDF] |
||||
Read all eLetters